Zhi Jin Xu Selected Research

Renal Insufficiency (Renal Failure)

10/2020

Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi Jin Xu Research Topics

Disease

3	Chronic Cough 01/2021 - 01/2020
2	Cough 01/2020 - 01/2020
1	Overweight 02/2023
1	Obesity 02/2023
1	Body Weight (Weight, Body) 02/2023
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Renal Insufficiency (Renal Failure) 10/2020
1	Dysgeusia (Parageusia) 01/2020
1	Vesicular Stomatitis 01/2017

Drug/Important Bio-Agent (IBA)

3	GefapixantIBA 01/2021 - 01/2020
2	Purinergic P2X3 ReceptorsIBA 01/2020 - 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 02/2023
1	ertugliflozinIBA 02/2023
1	Sitagliptin Phosphate (Januvia)FDA Link 10/2020
1	dapagliflozinIBA 10/2020
1	Purinergic Receptors (Receptors, Purine)IBA 01/2020
1	VaccinesIBA 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017

Therapy/Procedure

1	Glycemic Control 10/2020